This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignees: Padlock Therapeutics, Inc., Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2017-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 6 
1 out of 1,335 
Years Active: 2017-2018
Title: The Innovative Contributions of Adrian Kotey
Introduction
Adrian Kotey is a notable inventor based in Abingdon, GB, recognized for his significant contributions to the field of medicinal chemistry. With a total of three patents to his name, he has made strides in developing compounds that address critical health issues.
Latest Patents
Among his latest patents, Kotey has developed bicyclic inhibitors of PAD4. This invention provides compounds that are useful as inhibitors of PAD4, along with compositions and methods for treating PAD4-related disorders. Another significant patent involves sepiapterin reductase inhibitors, which disclose inhibitors of sepiapterin reductase and their applications in analgesia, treatment of acute and chronic pain, anti-inflammation, and immune cell regulation.
Career Highlights
Throughout his career, Kotey has worked with esteemed organizations such as Padlock Therapeutics, Inc. and the Max Planck Society for the Advancement of Science. His work in these institutions has allowed him to collaborate on groundbreaking research and development projects.
Collaborations
Some of his notable coworkers include Heather Tye and Rajesh Devraj, who have contributed to his innovative endeavors.
Conclusion
Adrian Kotey's work exemplifies the impact of innovation in the field of medicinal chemistry. His patents not only showcase his inventive spirit but also highlight the potential for advancements in treating various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile